-
1
-
-
33744498515
-
nd report
-
Geneva: WHO
-
nd report. WHO Tech Rep Ser 982, Geneva, WHO, 2013
-
(2013)
WHO Tech Rep Ser 982
-
-
-
2
-
-
33845588777
-
Assessing the burden of rabies in India. Results of a national multi-centre epidemiological survey
-
M.K.Sudarshan, S.N.Madhusudana, B.J.Mahendra, N.S.Rao D.H.Ashwathnarayana, S.Abdul Rahman, F.X.Meslin, D.Lobo, K.Ravikumr, Gangaboriah. Assessing the burden of rabies in India. Results of a national multi-centre epidemiological survey. Int J Infect Dis, 2007; 11:29-35
-
(2007)
Int J Infect Dis
, vol.11
, pp. 29-35
-
-
Sudarshan, M.K.1
Madhusudana, S.N.2
Mahendra, B.J.3
Rao, N.S.4
Ashwathnarayana, D.H.5
Abdul Rahman, S.6
Meslin, F.X.7
Lobo, D.8
Ravikumr, K.9
-
3
-
-
84976475678
-
-
ed, Rabies 3d ed, Oxford: Academic Press, pp
-
L.H.Taylor, P.Costa, D.J.Briggs. Public health management of humans at risk. In: A.C.Jackson (ed) Rabies 3d ed. Oxford, Academic Press pp 543-573
-
Public health management of humans at risk. In
, pp. 543-573
-
-
Taylor, L.H.1
Costa, P.2
Briggs, D.J.3
Jackson, A.C.4
-
4
-
-
0034597383
-
Diffusion and fate of intramuscularly injected human rabies immune globulin
-
10974171
-
N.Saesow, T.Chaiwatanarat, C.Mitmoonpitak, H.Wilde. Diffusion and fate of intramuscularly injected human rabies immune globulin. Acta Trop. 2000; 76(3):289-92; PMID:10974171; http://dx.doi.org/10.1016/S0001-706X(00)00107-8
-
(2000)
Acta Trop.
, vol.76
, Issue.3
, pp. 289-292
-
-
Saesow, N.1
Chaiwatanarat, T.2
Mitmoonpitak, C.3
Wilde, H.4
-
5
-
-
0000798133
-
Studies on the local treatment of rabies infected wounds
-
D.J.Dean, G.M.Bear, W.R.Thompson. Studies on the local treatment of rabies infected wounds. Bull World Hlth Org 1963; 28:477-84
-
(1963)
Bull World Hlth Org
, vol.28
, pp. 477-484
-
-
Dean, D.J.1
Bear, G.M.2
Thompson, W.R.3
-
6
-
-
84884626033
-
Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies; results of in vitro and in vivo studies
-
S.N.Madhusudana, B.Y.Ashwin, S.Sudarsahan. Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies; results of in vitro and in vivo studies. Hum Vaccine Immunother 2013; 9:1914-7; http://dx.doi.org/10.4161/hv.25431
-
(2013)
Hum Vaccine Immunother
, vol.9
, pp. 1914-1917
-
-
Madhusudana, S.N.1
Ashwin, B.Y.2
Sudarsahan, S.3
-
7
-
-
35048833272
-
Failures of post-exposure rabies prophylaxis
-
17905484
-
H.Wilde. Failures of post-exposure rabies prophylaxis. Vaccine 2007; 25:7605-9; PMID:17905484; http://dx.doi.org/10.1016/j.vaccine.2007.08.054
-
(2007)
Vaccine
, vol.25
, pp. 7605-7609
-
-
Wilde, H.1
-
9
-
-
84898056625
-
Survival from rabies encephalitis
-
A.de Souza, S.N.Madhusudana. Survival from rabies encephalitis. J Neurol Sci 2014; 339:8-14; http://dx.doi.org/10.1016/j.jns.2014.02.013
-
(2014)
J Neurol Sci
, vol.339
, pp. 8-14
-
-
de Souza, A.1
Madhusudana, S.N.2
-
10
-
-
78149260916
-
Sero-prophylaxis in experimental rabies
-
K.Habel. Sero-prophylaxis in experimental rabies. Pub Health Rep 1945; 60:545-8; http://dx.doi.org/10.2307/4585257
-
(1945)
Pub Health Rep
, vol.60
, pp. 545-548
-
-
Habel, K.1
-
11
-
-
0000733950
-
Use of hyper immune antirabies serum Concentrates in experimental rabies
-
15410721
-
H.Koprowsky, J.Van der Sheen, J.Blancau. Use of hyper immune antirabies serum Concentrates in experimental rabies. Am J Med 1950; 8: 412-4; PMID:15410721; http://dx.doi.org/10.1016/0002-9343(50)90224-5
-
(1950)
Am J Med
, vol.8
, pp. 412-414
-
-
Koprowsky, H.1
Van der Sheen, J.2
Blancau, J.3
-
12
-
-
0041582927
-
th report
-
WHO, Geneva:
-
th report. Tech Rep Ser 523 WHO Geneva, 1973
-
(1973)
Tech Rep Ser 523
-
-
-
14
-
-
84976509254
-
th report
-
WHO, Geneva:
-
th report. Tech rep Ser 824 WHO, Geneva, 1992
-
(1992)
Tech rep Ser 824
-
-
-
15
-
-
33744498515
-
nd report
-
WHO, Geneva:
-
nd report. Tech rep Ser 982, WHO Geneva, 2013
-
(2013)
Tech rep Ser 982
-
-
-
16
-
-
0014189044
-
Rabies Neutralizing Antibodies Response to Different Schedules of Serum & Vaccine inoculations in non–exposed persons: Part 4
-
5299668
-
P.Atanasiu, D.J.Dean et.al; Rabies Neutralizing Antibodies Response to Different Schedules of Serum & Vaccine inoculations in non–exposed persons: Part 4; Bull WHO; 1967; 36:361-365; PMID:5299668
-
(1967)
Bull WHO
, vol.36
, pp. 361-365
-
-
Atanasiu, P.1
Dean, D.J.2
-
17
-
-
0020065195
-
Excretion of rabies virus in saliva of rabid dogs
-
M.Fekadu, J.U.Shaddock, G.M.Baer. Excretion of rabies virus in saliva of rabid dogs. J Infect Dis 1982; 145:715-9
-
(1982)
J Infect Dis
, vol.145
, pp. 715-719
-
-
Fekadu, M.1
Shaddock, J.U.2
Baer, G.M.3
-
18
-
-
0002727951
-
The fluorescent antibody technique
-
In, eds, Geneva: WHO, pp
-
D.J.Dean, M.K.Ableseth, P.Atanasiue. The fluorescent antibody technique. In: F.X.Meslin, M.M.Kaplan, H.Koprowsky (eds) laboratory techniques in rabies 4t ed. Geneva, WHO 1996, pp 88-96
-
(1996)
Laboratory techniques in rabies 4t ed.
, pp. 88-96
-
-
Dean, D.J.1
Ableseth, M.K.2
Atanasiue, P.3
Meslin, F.X.4
Kaplan, M.M.5
Koprowsky, H.6
-
19
-
-
0001271311
-
A rapid fluorescent focus inhibition test for determining Rabies virus neutralizing antibody
-
In, eds, Geneva: WHO, pp
-
th ed. Geneva, WHO 1996, pp 181-192
-
(1996)
th ed
, pp. 181-192
-
-
Smith, J.S.1
Yager, P.A.2
Bear, G.M.3
Meslin, F.X.4
Kaplan, M.M.5
Koprowsky, H.6
|